Skip to content
Healthcare
KZActiveBIN 190640005198
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "БИОМЕД-А"

Director
Бондарчук Наталья Владимировна
Incorporated
05.06.2019
Address
Акмолинская область ул. М.АУЭЗОВА, 17
РНН
030400216736

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "БИОМЕД-А"
BIN
190640005198
Status
Active
Director
Бондарчук Наталья Владимировна
Registration date
05.06.2019
Activity
Прочая деятельность в области здравоохранения, не включенная в другие группировки
Legal address
Акмолинская область ул. М.АУЭЗОВА, 17

In government contracts over 2 years

  • Акмолинская область, Атбасарский район, г.Атбасар, М.АУЭЗОВА, 17 matches the registered one

    contract of 25.09.2026
VAT payer
Yes, since 02.04.2026
КАТО
113820100
РНН
030400216736
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 11 до 15 чел.

Has changed

Activities

1
86909primary

Прочая деятельность в области здравоохранения, не включенная в другие группировки

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
4.9M
2025
2.5M+33%
2024
1.8M+41%
2023
1.3M+555%
2022
199.7K+1075%
2021
17K
·4.9M
2026year to date
+33%2.5M
2025
+41%1.8M
2024
+555%1.3M
2023
+1075%199.7K
2022
·17K
2021
2026
Tax paid4,872,425 ₸
Penalty455,600 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid2,455,749 ₸
Penalty293,246 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid1,847,122 ₸
Penalty12,800 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid1,308,245 ₸
Penalty3,700 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid199,721 ₸
Penalty30 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid17,000 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • БН

    Бондарчук Наталья Владимировна

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "БИОМЕД-А" (BIN 190640005198) is an active legal entity in Акмолинская область, registered in 2019 (7 years on the market). Primary activity — прочая деятельность в области здравоохранения, не включенная в другие группировки. Per open government registries as of November 10, 2026: 151 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 32,850,471 ₸. Automated screening of open registries found no risk indicators for "БИОМЕД-А". Director on record — Бондарчук Наталья Владимировна. Data current as of November 10, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.